Dexter Yan specializes in Implementation at AGMI, where he co-leads the Firm's global implementation and transformation arms. He partners with senior leadership teams across life sciences and MedTech to diagnose operational inefficiencies and deliver high-impact solutions in strategic implementation, digital transformation, and supply chain optimization. He has over a decade of experience driving measurable improvements in performance, efficiency, and resilience throughout the healthcare value chain.
Prior to AGMI, Dexter was an Implementation Management Consultant at McKinsey & Company, where he conducted in-depth operational analyses for leading life sciences clients: designing and executing optimized drug manufacturing programs that significantly boosted annual throughput; enhancing MedTech supply chain strategies to drive On-Time In-Full performance; and rolling out tiered huddle structures to embed sustainable performance management.
Earlier in his career, Dexter led strategic assessments for large biopharmaceutical organizations (identifying millions in potential FTE savings and crafting actionable roadmaps to optimize capacity) and directed enterprise-wide digital transformations, including digital performance management and Electronic Batch Record (EBR) systems, yielding significant efficiency gains, labor-cost savings, and reductions in non-conformances.
Dexter holds an MS in Plastics Engineering from the University of Massachusetts and a B Eng in Polymer Science and Engineering from the South China University of Technology.
Discover the story behind our beginnings and vision for the future
Our firm was born from a shared vision among seasoned leaders, many of whom honed their deep domain expertise in the Life Sciences and Healthcare through PhDs, and their strategic acumen at consultancy firms like McKinsey & Co. We observed that traditional strategic frameworks often needed a modern lens to navigate the intricate execution challenges unique to incorporating fresh ideas and burgeoning technologies across domain-specific value chains in complex environments. This insight brought our team together with a singular mission: to empower leaders in the life sciences and healthcare to thrive and lead, transforming their technical and scientific expertise into global impact.
Unlike traditional consultancies with add-on AI practices, we combine our profound, sector-specific domain expertise with AI-native capabilities. This combination is particularly critical in highly technical and regulated fields, where understanding the nuanced scientific, engineering, and operational realities is paramount to successfully unlocking the full potential of our clients.
With this philosophy, we partner closely with leaders across biopharma, biotech, and healthcare to tackle their most formidable challenges, drive meaningful change, accelerate innovation, and ultimately, help them achieve significant breakthroughs and lasting competitive advantage.
By embedding advanced analytics where appropriate (refer to our white paper, “To AI or Not to AI : Critical Business Functions in Biopharma and Biotech“), we ensure our incentives are aligned with yours. We are committed to driving real-world impact, to enable your business to thrive on the global stage, and to build lasting value.
0+
Successful cases of BD and licensing
We help businesses expand into the US and Asia-Pacific through strategic licensing partnerships that drive global growth
$0B+
Total market capitalization
We have partnered with companies valued at over $10 billion, driving revenue growth and enhancing market value through strategic insights and innovative solutions
0+
Fundraising and due-diligence projects
Our experienced team specializes in securing funding for businesses and mitigating investment risks through meticulous due diligence, driving sound decisions and sustainable growth